Microscale/ nanoscale material type |
Microscale/ nanoscale material application |
Base material |
Scaffold used |
Cell type |
In vivo |
Major result |
Ref. |
|
Microspheres |
The increase in the proliferation rate of MSCs and their chondrogenic differentiation. |
Gelatin |
Gelatin microsphere |
Human BMSCs |
— |
Culturing MSCs on gelatin microspheres accelerated proliferation rate and preserved stemness properties as well as enhanced chondrogenesis |
[31] |
Microspheres |
Delivery of rapamycin |
PLGA |
— |
Human chondrocytes |
Mice model |
Provided sustained and controlled release of rapamycin for several weeks and prevented OA-like changes in chondrocytes under genomic and oxidative stress conditions |
[29] |
Microspheres |
Verteporfin delivery |
Chitosan |
Collagen I-coated culture dish and PDMS substrates |
Human chondrocytes |
Mice model |
Provided a local sustained release of verteporfin and significantly maintained cartilage homeostasis in a mice OA model |
[72] |
Microspheres |
Microencapsulation of human osteoarthritic chondrocytes (hOACs) |
Collagen |
Collagen scaffold |
hOACs |
— |
Collagen microspheres, as a screening platform, better maintained the hOAC phenotype compared with the 2D monolayer and 3D pellet cultures |
[73] |
Microspheres |
As a scaffold |
Cartilage |
Cartilage microspheres |
Rabbit MSCs |
— |
Induced the in vitro chondrogenesis without adding any serum or induction components |
[74] |
Nanocapsules |
Celecoxib delivery |
HA |
— |
— |
Rat model |
Spherical shape, high entrapment efficiency (97.98%), prolonged drug release, and improved histopathology analysis |
[65] |
NPs |
Delivery of SM |
PLGA |
— |
— |
Rat model |
Increased the chondroprotective effects of SM |
[68] |
NPs |
KGN delivery |
PLGA |
m-HA |
— |
Porcine model |
Improved hyaline cartilage and subchondral bone repair and demonstrated better therapeutic efficacy in full-thickness chondral defects |
[71] |
NPs |
Melatonin delivery |
Albumin |
PCL scaffold |
Human chondrocytes |
— |
Prolonged the drug release for 22 days and increased GAG deposition |
[75] |
Nanotubes |
Cartilage repair |
Carboxylated SWCNTs |
SWCNTs/BSA/collagen composite scaffold |
BMSCs |
Rabbit model |
Had no cytotoxic effect on BMSCs, improved mechanical properties and cell proliferation, and repaired cartilage defects in a rabbit model |
[76] |
Electrospun nanofibers |
Scaffold fabrication |
ECM/PCL hybrid |
Cartilage-derived ECM/PCL composite |
Rabbit chondrocyte |
Mice model |
Considerably promoted the proliferation of chondrocytes in vitro and facilitated the regeneration of cartilage in vivo |
[77] |
Electrospun nanofibers |
Fabrication of a biocompatible scaffold |
PLA/gelatin |
CS-modified nanofibers |
Rabbit BMSCs |
Rabbit model |
Had appropriate mechanical properties and suitable biocompatibility, showed better chondrogenic differentiation and promoted cartilage regeneration |
[78] |
Electrospun nanofibers |
Fabrication of scaffold |
PLLA |
The PLLA/PDA/CS membranes |
Rabbit chondrocytes/rabbit BMSCs |
Rabbit model |
Considerably facilitated the filling of the defect site and the generation of hyaline-like cartilage in vivo |
[79] |
Electrospun nanofibers |
Scaffold fabrication |
PCL/PEO |
PCL/PEO combined with MSCs-derived TE construct |
Rabbit synovial stem cells |
Rabbit model |
Significantly prevented meniscal extrusion, exerted a chondroprotective effect, and repaired meniscal defects |
[80] |
Nanocapsules |
Delivery of TGF-β1 |
Gelatin and iron oxide |
— |
ATDC5 cells |
— |
Magnetic gelatin nanocapsules improved the differentiation of ATDC 5 cells with the increased expression of Col2a1 and aggrecan |
[81] |
Nanocrystal– polymer particles |
Delivery of p38α/β MAPK inhibitor |
PLA |
— |
Human OA synoviocytes |
Mice model |
Were non-toxic to cultured human OA synoviocytes, exhibited good retention in the joint and adjacent tissues, and also decreased inflammation and joint degradation |
[67] |
Nanofibers |
Fabrication of collagen-like nanorods |
Chitosan and polydiisopropyl fumarate |
Fumarate copolymer– chitosan crosslinked nanofibers |
Rat BMPCs/rat chondrocytes |
— |
Supported cell attachment and growth, as well as promoted both osteogenic and chondrogenic differentiation |
[82] |
NPs |
Delivery of curcuminoid |
HA/chitosan |
— |
Rat chondrocytes |
Rat model |
Provided prolonged release of curcuminoid, inhibited NF-kB signaling and the expression of MMP-1 and MMP-13, and upregulated the expression of type-II collagen in chondrocytes in vitro, as well as reduced the Outerbridge classification and Mankin pathological scores in a knee OA model |
[69] |
Nanogels |
Encapsulation of TGF-β3 |
Alginate |
— |
hMSCs |
— |
Significantly reduced burst release, provided the sustained release of TGF-β3, and also resulted in better chondrogenic differentiation of hMSCs |
[83] |
Nano- composites |
Fabrication of scaffold |
PLDLA/HAp |
PLDLA/HAp enriched with sodium alginate |
— |
Rabbit model |
Improvement in articular cartilage defect treatment |
[84] |
Dendrimer |
Delivery of KGN |
PEGylated PAMAM |
— |
BMSCs |
Rat model |
KGN-PEG-PAMAM conjugate could induce higher expression of chondrogenic markers |
[85] |
NPs |
Providing high RGD surface density |
Gold |
— |
hMSCs |
— |
Had a promotive effect on cartilaginous matrix production and marker gene expression |
[86] |
Dendrimers |
Providing a surface for cell attachment |
PAMAM |
A PAMAM surface with fifth-generation (G5) dendron structure. |
hMSCs |
— |
Affected the expression of type-II and type-X collagens via effects on cell aggregate behavior |
[87] |
Magnetic NPs |
Labeling of chondrocytes |
Iron oxide |
Collagen-chitosan/PLGA |
Rabbit chondrocytes |
— |
Magnetic nanoparticles did not affect the cell phenotype and provided a technique for tracking cartilage regeneration and osteochondral defect repair |
[88] |
Nanofibers |
Fabrication of nanofiber-based scaffold |
PLGA |
PLGA |
hMSCs |
— |
Induced MSC differentiation into bone and cartilage |
[89] |
Nanofibers |
Fabrication of scaffold |
PLLA-PCL- collagen |
PLLA-PCL- collagen/HA |
Rabbit MSCs |
— |
Promoted orientation, adhesion and proliferation of BMSCs as well as expression of chondrogenic markers |
[90] |
Magnetic NPs |
Physical stimuli |
Magnetic NPs isolated from Magneto- spirillm sp. |
Micromass culture system used |
hMSCs |
— |
Enhanced the level of sulfated glycosaminoglycan (GAG) and collagen synthesis,and facilitated chondrogenic differentiation |
[91] |
NPs |
KGN delivery |
Chitosan |
— |
hMSCs |
Rat model |
Provided the sustained release of KGN and induced higher expression of chondrogenic markers |
[92] |
NPs |
Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein |
PLGA |
— |
hMSCs |
Mice model |
Highly expressed chondrogenesis-related extracellular matrix (ECM) components |
[93] |
Nanofibers |
Fabrication of electrospun embedded nanocomposite. |
PLLA |
PEG-POSS/PLLA |
hMSCs |
— |
hMSCs were able to attach, proliferate, and differentiate into chondrocytes |
[94] |
NPs |
Delivery of pDC316-BMP4-EGFP Plasmid |
PLGA |
PLLGA |
Rabbit ADSCs |
Rabbit model |
BMP-4 plasmid could be successfully delivered into ADSCs by PLGA nanoparticles and promoted in vitro and in vivo chondrogenesis |
[95] |
Electrospun nanofibers |
Fabrication of scaffold. |
PCL |
PCL |
Human MenSCs |
— |
Induced chondrogenic differentiation of menstrual blood derived stem cells |
[96] |
NPs |
TGF-β1 gene delivery. |
Calcium phosphate |
Collagen/chitosan |
Rat MSCs |
— |
Could successfully induce MSC chondrogenic differentiation |
[97] |
Nanotubes |
Providing titanium dioxide (TiO2) based surface. |
TiO2
|
TiO2 nanotube |
Limb mesenchymal cells |
— |
Could support chondrocytic functions |
[98] |
Nanofibers |
Fabrication of scaffold. |
PLLA |
PLLA |
hMSCs |
— |
Expressed cartilage-specific gene and formed typical cartilage morphology |
[99] |
Nanofibers |
As scaffold |
PCL |
PCL |
hMSCs/pig chondrocyte |
Swine model |
Showed the most complete repair, generated hyaline-like cartilage tissue, and had the highest equilibrium compressive stress (1.5 MPa) in the regenerated cartilage |
[100] |